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To identify progressive supranuclear palsy (PSP), we combined voxel-based
morphometry (VBM) and support vector machine (SVM) classification using
disease-specific features in multicentric magnetic resonance imaging (MRI) data.
Structural brain differences were investigated at four centers between 20 patients with
PSP and 20 age-matched healthy controls with T1-weighted MRI at 3T. To pave the
way for future application in personalized medicine, we applied SVM classification to
identify PSP on an individual level besides group analyses based on VBM. We found
a major decline in gray matter density in the brainstem, insula, and striatum, and
also in frontomedian regions, which is in line with current literature. Moreover, SVM
classification yielded high accuracy rates above 80% for disease identification in imaging
data. Focusing analyses on disease-specific regions-of-interest (ROI) led to higher
accuracy rates compared to a whole-brain approach. Using a polynomial kernel (instead
of a linear kernel) led to an increased sensitivity and a higher specificity of disease
detection. Our study supports the application of MRI for individual diagnosis of PSP, if
combined with SVM approaches. We demonstrate that SVM classification provides high
accuracy rates in multicentric data—a prerequisite for potential application in diagnostic
routine.
Keywords: magnetic resonance imaging, progressive supranuclear palsy, atypical parkinsonism, support vector
machine classification, voxel-based morphometry
INTRODUCTION
Progressive supranuclear palsy (PSP) is a neurodegenerative disease with a clinical syndrome
including atypical parkinsonism, supranuclear palsy, postural instability, and dementia.
Neuropathologically, PSP is characterized by the accumulation of tau protein (tauopathy), resulting
in neurofibrillary tangles and affecting both neurons and glial cells (Williams and Lees, 2009). It is
associated with structural changes in the midbrain, also called “hummingbird” or “penguin sign”.
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Recently, several studies investigated the pattern of PSP-
related structural brain changes using magnetic resonance
imaging (MRI) in combination with an analysis technique called
voxel-based morphometry (VBM). These studies present, at least
partly, conflicting results. Many studies found a diminished gray
matter density (GMD) in the left and right insulae (Brenneis
et al., 2004; Padovani et al., 2006; Ghosh et al., 2012). Several
papers reported a reduced GMD in the thalamus (Cordato et al.,
2005; Boxer et al., 2006; Padovani et al., 2006; Shi et al., 2013),
but other papers did not find GMD changes here (Brenneis
et al., 2004; Ghosh et al., 2012). Volumetric analysis of structural
MRI showed a significantly smaller putamen in PSP patients in
comparison to healthy controls (Messina et al., 2011). Recently,
quantitative and systematic meta-analyses have been introduced
to imaging data to identify the prototypical neural correlates of
neurodegenerative diseases (Schroeter et al., 2007, 2008, 2009).
Meanwhile three comprehensive meta-analyses have applied
methods like anatomical likelihood estimates or effect-size signed
differential mapping to PSP studies (Shi et al., 2013; Shao et al.,
2014; Yu et al., 2015). By investigating gray matter changes, these
meta-analyses consistently identified the thalamus, basal ganglia,
insula, and midbrain as the disease-specific core network of PSP.
Our study aimed at further investigating structural brain
changes associated with PSP by using MRI and VBM using a
multicentric approach. We included a cohort of 20 patients and
20 healthy control subjects. Note that 20 patients is a relatively
large cohort because of the low prevalence of PSP. We included
11 patients from Germany (Ulm, Homburg, Leipzig) and 9
patients from the Czech Republic (Prague). In order to assess
the effect of the different locations and scanning conditions,
we analyzed the Czech participants separately, because all
Czech participants were scanned under identical conditions. In
addition, we also performed a conjunction analysis using the
Czech and the German cohort. A high degree of similarity
between the VBM results of both cohorts would demonstrate that
the effects of PSP in terms of brain degeneration are large enough
to be shown across different centers using VBM.
Another aim of the study was the individual classification
of PSP patients and healthy controls by machine learning
pattern recognition algorithms applied to imaging data with
our multi-centric approach. Here, we performed support vector
machine (SVM) classification (Chang and Lin, 2011) on the
basis of GMD images obtained with VBM. In two recent studies,
this approach was already used to classify PSP patients from
healthy controls within a unicentric setting (Focke et al., 2011;
Salvatore et al., 2014). We demonstrate that high accuracy rates
can also be obtained across different centers. Furthermore, the
availability of multicentric data for the training of a classifier is
a major advantage in the reliable detection of a rare condition.
Recently, multicentric SVM classification was shown to achieve
high accuracy rates for the differentiation between Alzheimer’s
disease and frontotemporal lobar degeneration (Dukart et al.,
2013). Dukart and colleagues used disease-specific regions of
interest (ROI) for SVM feature selection instead of using all brain
regions. The ROIs were selected according to comprehensive
meta-analyses. Similar to their approach (Dukart et al., 2013)
and in contrast to other recent work (Focke et al., 2011; Salvatore
et al., 2014), we used disease-specific ROIs based on meta-
analytically extracted prototypical neural networks for PSP (Shi
et al., 2013; Shao et al., 2014; Yu et al., 2015) and performed
SVM classification using the voxels within these ROIs for feature
selection in addition to whole-brain analyses. Note that the ROIs
are defined here (Shi et al., 2013; Shao et al., 2014; Yu et al.,
2015) in an independent cohort in a data-driven manner. We
compared the resulting accuracy rates with the results from a
whole-brain approach, expecting higher accuracy rates within
the ROI-based technique. In addition, we validated the influence
of different kernel functions and different approaches of feature
selection on results.
METHODS
Subjects
A cohort of 20 PSP patients (7 female, age 67.3 ± 7.8 years,
mean ± standard deviation) was compared to a group of 20 age-
and gender-matched healthy control subjects (8 female, age 66.3
± 7.8 years). Multicentric data were obtained in Germany and
the Czech Republic (see Table 1 for demographic details). The
German cohort of 11 patients (4 female, age 69.0 ± 9.3 years)
and 11 controls (4 female, 68.1 ± 7.8 years) was chosen from the
data of the Consortium for Frontotemporal Lobar Degeneration
at the centers of Ulm, Homburg, and Leipzig. The Czech sub-
cohort of 9 patients (3 female, 65.2± 5.4 years) and 9 controls (4
female, 64.2 ± 7.6 years) was selected in Prague under identical
conditions and was, therefore, additionally used to perform a
unicentric analysis. Mean age and age variability did not differ
between cohorts as investigated by two-tailed two-sample t-
tests and F-tests for equal variances (all comparisons p > 0.2).
The study was approved by the local ethics committees (Ethics
Committee of the General University Hospital in Prague, Czech
Republic; Ethics Committee of the University of Ulm, Germany;
Ethics Committee of the University of Leipzig, Germany; Ethics
Committee of the SaarlandMedical Board, Homburg, Germany).
All participants were carefully informed about the study and gave
signed written consent in accordance with the Declaration of
Helsinki.
Data Acquisition
T1-weighted structural brain images were acquired at all
four centers using the magnetization-prepared rapid gradient-
echo (MP-RAGE) sequence implemented on 3T MAGNETOM
scanners (Siemens, Erlangen, Germany; Prague: MAGNETOM
Trio; Ulm: MAGNETOM Allegra; Homburg: MAGNETOM
Skyra; Leipzig: MAGNETOM Verio). All images were acquired
with a nominal resolution of 1 × 1 × 1mm3. Further imaging
parameters are listed in Table 2. Note that the same acquisition
parameters were used inHomburg and Leipzig, whereas a slightly
different set of parameters was used at the other two sites, Prague
andUlm (longer echo time with a smaller imaging bandwidth per
pixel).
VBM Analysis
Image processing was performed using the VBM 8 toolbox
rev. 435 (Structural Brain Mapping Group, University of Jena,
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TABLE 1 | Demographical and scanner data for patients and control subjects.
Patient ID Age (years) Sex City Scanner Control ID Age (years) Sex City Scanner
P08DE 55 m Ulm Allegra C39DE 73 m Ulm Allegra
P42DE 74 f Ulm Allegra C54DE 78 m Ulm Allegra
P40DE 61 f Ulm Allegra C72DE 75 f Ulm Allegra
P48DE 65 m Ulm Allegra C82DE 73 m Ulm Allegra
P50DE 64 m Ulm Allegra C85DE 71 f Ulm Allegra
P72DE 60 m Ulm Allegra C91DE 71 m Ulm Allegra
P55DE 79 f Leipzig Verio C64DE 54 f Leipzig Verio
P79DE 70 m Leipzig Verio C80DE 64 m Leipzig Verio
P15DE 85 m Homburg Skyra C22DE 72 m Leipzig Verio
P32DE 67 f Homburg Skyra C49DE 61 f Leipzig Verio
P92DE 79 m Homburg Skyra C46DE 57 m Leipzig Verio
P01CZ 68 m Prague Trio C04CZ 65 f Prague Trio
P08CZ 69 f Prague Trio C06CZ 66 f Prague Trio
P12CZ 64 m Prague Trio C07CZ 72 f Prague Trio
P15CZ 61 f Prague Trio C09CZ 58 m Prague Trio
P18CZ 61 m Prague Trio C19CZ 54 m Prague Trio
P21CZ 75 f Prague Trio C25CZ 61 m Prague Trio
P26CZ 69 m Prague Trio C29CZ 56 m Prague Trio
P32CZ 58 m Prague Trio C31CZ 70 f Prague Trio
P33CZ 62 m Prague Trio C34CZ 76 m Prague Trio
CZ, Czech Republic; DE, Germany; f, female; m, male.
TABLE 2 | Acquisition parameters of the MP-RAGE sequence at all four imaging centers.
Imaging center Prague Ulm Leipzig Homburg
Scanner Trio Allegra Verio Skyra
Software syngo MR B17 syngo MR A30 syngo MR B17 syngo MR D11
Flip angle 10◦ 8◦ 9◦ 9◦
Repetition time(ms) 2,300 2,200 2,300 2,300
Echo time(ms) 4.43 4.38 2.98 2.96
Inversion time(ms) 900 1,200 900 900
Bandwidth(Hz/Px) 150 130 238 240
FoV 240 × 256 256 × 256 240 × 256 240 × 256
Image matrix 240 × 256 × 160 256 × 256 × 208 240 × 256 × 176 240 × 256 × 176
Nominal resolution(mm3 ) 1 × 1 × 1 1 × 1 × 1 1 × 1 × 1 1 × 1 × 1
MP-RAGE, magnetization-prepared rapid gradient-echo; FoV, field of view; Px, pixel.
Department of Psychiatry, Germany) with Statistical Parametric
Mapping 12 rev. 6,470 (The Wellcome Trust Centre for
Neuroimaging, UCL, London, UK) and MATLAB 8.6 (R2015b,
MathWorks, Inc, Natick, MA). GMD images were generated
using the unified segmentation approach that presents a
probabilistic framework combining image registration, tissue
classification, and bias correction (Ashburner and Friston, 2005).
Each voxel within the GMD images contains a measure of
gray matter probability obtained by the unified segmentation
approach. In order to account for volume changes during
normalization, GMD was scaled by the amount of non-
linear deformation that is also called modulation. To meet
the assumptions of random field theory, GMD images were
finally smoothed with a Gaussian kernel of 8-mm full-width
at half-maximum (FWHM). Voxel-wise statistical analysis was
performed with the general linear model implementing a two-
sample t-test to compare PSP patients with healthy participants,
controlling for age, sex, and total intracranial volume. Clusters
were detected using a voxel-threshold of p< 0.001. To correct for
multiple comparisons, a minimum cluster size of k > 1,000 was
chosen to detect significant clusters with p < 0.05, family-wise
error (FWE) corrected threshold on the cluster level (Nichols and
Hayasaka, 2003).
To study effects induced by a single center, and to assess
between-center variability arising from different location and
hardware, statistical analyses were performed separately with
patients and controls from Prague (unicenter approach) and
with patients and controls from the German centers (multicenter
Frontiers in Neuroscience | www.frontiersin.org 3 March 2017 | Volume 11 | Article 100
Mueller et al. Identifying Progressive Supranuclear Palsy
approach). Due to the smaller numbers of patients in both
subcohorts, a voxel-threshold of p < 0.005 was used. However,
a minimum cluster size of k > 1,000 was again used to report
significant clusters at p < 0.05, FWE-corrected. A conjunction
analysis was performed including the Czech and the German
cohort to investigate the overlap of the results between both
groups of participants.
To test the variability between the German centers, a second
conjunction analysis was performed using two cohorts generated
by merging the participants from Prague and Ulm, and by
merging the participants from Prague, Homburg, and Leipzig
(Homburg and Leipzig used identical scanning parameters, see
Table 2). In both cohorts, two-sample t-tests were performed to
detect significant GMD differences between patients and controls
using the same threshold as in the conjunction analysis described
above (voxel-threshold of p < 0.005 in combination with a
minimum cluster size of k> 1,000). Results of both analyses were
combined using a conjunction analysis to investigate the overlap.
SVM Analysis
In order to differentiate PSP patients from healthy controls,
SVM classification was performed with GMD images using the
libSVM software package rev. 3.18 (Chang and Lin, 2011). The
libSVM package offers open source software using the sequential
minimization optimization algorithm (Platt, 1998) supporting
SVM classification and regression. Classification accuracy was
obtained by cross-validation using the “leave one out” approach
by generating a set of 400 models, leaving a patient and a
control subject out when building the classifier. Thereafter,
it was checked if both remaining data sets were classified
correctly. Sensitivity and specificity were computed from the
number of correctly classified patients and controls. To assess
the stability of classification results depending on kernel type and
feature selection, the analysis was performed with two different
kernels (linear, polynomial) and two different approaches of
feature selection. First, voxels were used with SPM’s gray matter
tissue probability map using different minimum gray matter
probabilities between 0 and 80% (all thresholds are listed in
Table 3). Before thresholding, the gray matter tissue probability
map was interpolated to meet the resolution of the GMD images
obtained by using the VBM toolbox as described above. The gray
matter tissue probability map was also smoothed with a Gaussian
kernel of 8-mm FWHM, which is the same filter that was applied
to the GMD images.
The second approach of feature selection was based on
disease-specific ROIs. ROIs were extracted from comprehensive
meta-analyses on structural MRI changes in the gray matter in
PSP from the literature (systematic literature search in PubMed
on June 14, 2016, search terms: supranuclear palsy, meta-analysis,
VBM). Based on three relevant meta-analyses (Shi et al., 2013;
Shao et al., 2014; Yu et al., 2015), the disease-specific ROIs
included the thalamus, basal ganglia, midbrain, and insula,
because these brain regions were consistently impaired across
all meta-analyses. Note that the definition of disease-specific
ROIs in our study was based on comprehensive meta-analyses
independent from our data and conducted across whole-brain
studies only. ROIs were defined with the WFU-Pickatlas across
the aforementioned brain regions. Finally, a model was generated
from all patients and controls, and weights of voxels most
relevant for SVM classification were detected using the libSVM
package (Chang and Lin, 2011).
RESULTS
The VBM analyses revealed a major decline in GMD in
PSP patients compared to healthy controls. In particular, a
TABLE 3 | Accuracy, sensitivity, and specificity of support vector machine (SVM) classification with cross-validation generating 400 models excluding a
patient and a healthy control when building the classifier.
Linear kernel Polynomial kernel
PSP Ac (%) HC Ac (%) Sens (%) Spec (%) PSP Ac (%) HC Ac (%) Sens (%) Spec (%)
0.8 200 50 320 80 71 62 240 60 308 77 72 66
0.7 259 65 360 90 87 72 313 78 335 83 83 79
0.6 305 76 343 86 84 78 320 80 336 84 83 81
0.5 295 74 341 85 83 76 320 80 329 82 82 80
0.4 281 70 340 85 82 74 317 79 337 84 83 80
0.3 281 70 339 85 82 74 317 79 337 84 83 80
0.2 282 70 339 85 82 74 318 80 338 84 84 80
0.1 282 70 340 85 82 74 318 80 338 84 84 80
0.001 281 70 340 85 82 74 318 80 338 84 84 80
M1 299 75 360 90 88 78 337 84 345 86 86 85
M2 339 85 330 82 83 84 340 85 323 81 82 84
M3 337 84 342 86 85 84 340 85 294 74 76 83
M4 299 75 357 89 87 78 340 85 316 79 80 84
Columns with progressive supranuclear palsy (PSP) patients and healthy controls (HC) show the number of correctly classified participants for two different ways of generating models
using a linear and a polynomial kernel. Feature selection was performed with SPM’s gray matter tissue probability map using different thresholds, and with three different masks generated
by the WFU Pickatlas (Masks: M1 = putamen+pallidum+midbrain; M2 = M1+caudate; M3 = M2+thalamus; M4 = M3+insulae).: Ac, Accuracy; Sens, Sensitivity; Spec, Specificity.
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diminished GMD was observed in the brainstem, thalamus,
left and right anterior insulae, and also in wide regions in
the putamen extending to the pallidum (Figure 1, color-
coded in yellow/orange). Less prominent differences were
detected in lateral orbitofrontal and frontomedian regions.
The same regions were obtained when investigating GMD
differences in the multicentric German cohort with patients
and controls from three different centers (Ulm, Homburg,
and Leipzig, Figure 2, color-coded in yellow/orange).
The German PSP patients showed a diminished GMD
in the brainstem, insula, and putamen/pallidum in both
hemispheres. Smaller effects were also obtained in frontomedian
regions.
The conjunction analysis between the results obtained with
the Prague cohort and German cohort revealed a consistent
picture of GMD decline in PSP patients compared to controls.
We obtained a remarkably large overlap of brain regions affected
by PSP in both analyses with the German and Czech participants
(Figure 3, colored in yellow). The overlap revealed a reduced
GMD in patients not only in the putamen and pallidum but also
in the insular cortex (colored in yellow). The German cohort
showed prominent GMD reductions in the brainstem (colored
in red), while the Prague cohort also showed diminished GMD in
frontomedian regions (colored in blue).
Figure 4 shows the conjunction between PSP-related GMD
decrease obtained from two different cohorts obtained by
FIGURE 1 | Sagittal, coronal, and axial brain slices showing significant gray matter density (GMD) differences between 20 patients with progressive
supranuclear palsy (PSP) and 20 age- and sex-matched healthy controls (HC) (color-coded in red/yellow, p < 0.001, k > 1,000, controlled for multiple
comparisons using family-wise error-correction with p < 0.05 on the cluster level). In PSP patients, a diminished GMD was observed in the brain stem,
insula, frontal cortex, and also in wide regions of the putamen extending to the pallidum.
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FIGURE 2 | Orthogonal brain sections showing significant gray matter density (GMD) differences between patients with progressive supranuclear
palsy (PSP) and healthy controls (HC) (color-coded in red/yellow, p < 0.005, k > 1,000) in the German cohort. Significant clusters are shown using
family-wise error-correction with p < 0.05 on the cluster level.
merging the participants from Prague and Ulm, and by merging
the participants from Prague, Leipzig, and Homburg. An overlap
of GMD decrease was observed in the thalamus, putamen, insula,
and frontomedian and frontolateral regions (Figure 4, color-
coded in yellow).
Using SVM classification with a polynomial kernel and a
feature selection of voxels within SPM’s gray matter mask
with different minimum gray matter probabilities, PSP patients
were identified with classification accuracy up to 80%. Healthy
controls were detected with classification accuracy up to 84%
(Table 3). The resulting sensitivity was up to 84% and the
specificity was up to 81%. Interestingly, we received similar
results using different gray matter probabilities ≤60% when
choosing voxels within SPM’s gray matter mask (Table 3). This
demonstrates the robustness of SVM classification with respect to
feature selection dependent on the minimum gray matter tissue
probability. Using a linear kernel, accuracy values were generally
lower for the PSP patients at around 70%.
The disease-specific ROI-based SVM approach focusing on
the pallidum, putamen, caudate nucleus, thalamus, midbrain,
and insula as PSP’s core network generally outperformed the
classification with all gray matter voxels of the brain with respect
to disease detection and specificity of classification (Table 3,
Figure 5). Using different ROIs and a polynomial kernel, we
obtained accuracy rates above 84% for detecting PSP patients,
which outperformed all other whole-brain approaches using
minimum gray matter probabilities (see rows with masks M1–
M4 in Table 3). Accuracies for detecting healthy control subjects
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FIGURE 3 | Conjunction analysis showing both the unicentric Prague cohort (color-coded in blue) and the multicentric German sample (Ulm,
Homburg, and Leipzig, color-coded in red, see also Figure 2) showing significant gray matter density (GMD) differences between patients with
progressive supranuclear palsy (PSP) and healthy controls (HC) (p < 0.005, k > 1,000). The overlap (color-coded in yellow) shows a reduced GMD in patients
in the putamen extending to the pallidum, and also in the insular cortex. The German cohort showed prominent GMD reductions in the brainstem, while the Prague
cohort also showed diminished GMD in frontomedian regions.
varied between 74 and 86%, depending on the ROI. However, the
specificity was always above 83%.
Finally, when using a model for all patients and healthy
controls, relevant voxels for classification were observed in the
brainstem, putamen, pallidum, and caudate nuclei, but also
in cerebellar regions (Figure 5). Thus, using the whole-brain
approach (first row in Figure 5), we observed the same regions
that are discussed in the context of PSP in recent VBM studies
(Shi et al., 2013; Shao et al., 2014; Yu et al., 2015).
DISCUSSION
Several recent studies aimed at investigating structural gray
matter differences between PSP patients and controls using VBM
(Price et al., 2004; Cordato et al., 2005; Ghosh et al., 2012). In
line with these findings, we show a disease-related GMD decrease
using a multicentric approach based on a relatively large sample
of patients. A recent meta-analysis (Shi et al., 2013) investigating
nine VBM studies with a total of 143 PSP patients suggested
a crucial role of the insula and basal ganglia in PSP, which is
corroborated by our findings. However, the most prominent
finding (Shi et al., 2013) was a GMD decline in the thalamus,
which we obtained when restricting the analysis to patients
from Prague, Leipzig, and Homburg (see Figure 4, brain regions
colored in red). Note that the thalamus is not included in the list
of principal areas affected by the disease (Keith-Rokosh and Ang,
2008). Finally, we also found a major GMD reduction in gray
matter regions in the vicinity of the brainstem, which suggests
atrophy and seems to reflect the so-called hummingbird sign
proposed as a pathognomonic entity in PSP.
In a more recent meta-analysis, Yu et al. (2015) studied
39 VBM publications investigating brain atrophy in PSP,
corticobasal degeneration, and multisystem atrophy (MSA). In
total, 176 PSP patients were included in this analysis. In line
with our findings and the literature (Shi et al., 2013; Shao et al.,
2014), they reported brain atrophy in insular brain regions and
the thalamus. Our major result of GMD decrease in the putamen
and pallidum appears divergent from Yu et al. (2015): While we
excludedMSA patients from our cohort associating striatal GMD
decline with PSP, Yu and colleagues (Yu et al., 2015) showed
striatal GMD reduction solely for MSA, but not PSP. The authors
claim that striatal atrophy might distinguish MSA from PSP (see
Figure 2 in Yu et al., 2015). This is not in line with our findings,
which show a more complex and widespread involvement of
brain regions with PSP.
To distinguish different patterns of neurodegenerative
diseases, SVM classification across GMD maps can be a useful
tool beyond group comparisons. However, the question remains
as to whether it is possible to achieve a robust dissociation
between atypical Parkinson syndromes due to different patterns
of brain degeneration. In a recent study, Focke et al. (2011)
used SVM classification with a relatively small number of 10
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FIGURE 4 | Conjunction analysis showing significant gray matter density (GMD) differences (p < 0.005, k > 1,000) in two groups of participants
merging the participants from Prague and Ulm (U), and the participants from Prague, Homburg, and Leipzig (H/L). The overlap (color-coded in yellow)
shows major reductions of GMD in patients with progressive supranuclear palsy (PSP) in the thalamus, putamen, insula, and also in frontomedian and frontolateral
brain regions in comparison with healthy controls (HC).
PSP patients compared to 21 idiopathic Parkinson’s disease
(IPD) patients and 22 healthy controls. They did not observe a
significant distinction between PSP patients and healthy controls
based on GMD images (sensitivity 20%; accuracy 65.6%; see
Table 4 in Focke et al., 2011). This is quite surprising considering
the major GMD differences between PSP patients and controls
that we observed. We achieved sensitivity, specificity, and
accuracies above 80%. Relevant voxels for the SVM classification
were located in exactly the same regions as detected with the
VBM statistics investigating atrophy in PSP patients vs. controls.
This major difference between our findings and the results of
Focke et al. (2011) might be due to different disease stages or
different sample sizes of the PSP patients. Probably, a sample of
10 PSP patients is a limitation for achieving sufficient sensitivity
for classification. On the other hand, we also analyzed our
German (11 patients) and Czech (9 patients) cohorts separately
and received very similar GMD differences in both analyses
(shown by the conjunction analysis in Figure 3). Unfortunately,
Focke et al. (2011) did not show VBM comparisons between
PSP patients and healthy controls, but only GMD differences
between PSP and IPD; hence, whether the obtained differences
are predominantly based on PSP or IPD cannot be disentangled.
This within-disease comparison might be a reason why they
(Focke et al., 2011) did not detect GMD changes in the striatum
and insula, because of neurodegeneration in PSP and IPD in the
same brain regions. Their cerebellar findings might be related to
IPD and not to PSP. Note that both meta-analysis studies (Shi
et al., 2013; Yu et al., 2015) do not report involvement of the
cerebellum in PSP. It is even more interesting that Focke et al.
(2011) obtained a significant SVM classification between PSP
and IPD. However, they did not report a significant classification
between patients and healthy controls— neither for PSP nor for
IPD patients.
Amore recent study used SVM classification with quite a large
number of 28 PSP patients by performing a principal components
analysis (PCA) on T1-weighted structural images (Salvatore et al.,
2014). In contrast to the study of Focke et al. (2011), they
also obtained high accuracy rates in comparisons of PSP or
IPD patients with healthy controls with very similar patterns
of relevant voxels for both conditions (Salvatore et al., 2014).
Furthermore, they were able to dissociate PSP and IPD directly
with relevant voxels mainly detected in the thalamus (Shi et al.,
2013) and also in the cerebellum, which is in line with previous
findings (Focke et al., 2011). In agreement with our results,
Salvatore et al. (2014) detected relevant voxels in the medial
part of the midbrain, whereas the striatum and insula did not
contribute to their classification. This seems surprising because
of the involvement of these regions in PSP as consistently shown
in our study and previous meta-analyses (Shi et al., 2013; Yu
et al., 2015). Whereas Salvatore et al. (2014) performed the SVM
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FIGURE 5 | Weights of voxels most relevant for support vector machine (SVM) classification between both groups of patients with progressive
supranuclear palsy (PSP) and healthy controls (HC) after SVM training. Note that these weights are relative and have no applicable units. Relevant voxels are
located in the brain stem, putamen, and pallidum. Classification accuracy was obtained with a polynomial kernel using cross-validation generating a set of 400 models
leaving a patient and a control subject out when building the classifier. SVM classification was performed on all voxels within the SPM’s gray matter mask (tissue
probability >0.4, top row). The middle and the bottom row show the same analysis using regions of interest instead of all gray matter voxels (middle row: M1 =
putamen+pallidum+midbrain; bottom row: M4 = M1+caudate+thalamus+insulae).
analysis using a PCA on T1-weighted images, we applied SVM
to the GMD images. The combination of the SVM technique
with the VBM approach might be more sensitive for relating gray
matter changes in the striatum and insula to PSP.
Both previous SVM studies (Focke et al., 2011; Salvatore
et al., 2014) applied a linear kernel for SVM classification, which
reflects the default setting in the libSVM software package.
However, other kernels might be more suitable, leading to
higher accuracy rates and an improved sensitivity and specificity.
In a recent study, Huppertz et al. (2016) performed SVM
classification using a radial basis function (RBF) kernel. However,
the extraction of SVM weighting factors is mathematically only
defined for the linear kernel and not for an RBF kernel. Therefore,
the SVM approach was repeated with a linear kernel to identify
the most relevant regions for classification (Huppertz et al.,
2016). Motivated by a recent paper demonstrating the advantage
of using a polynomial kernel showing an improved accuracy
when dissociating mild cognitive impairment from Alzheimer’s
disease (Belmokhtar and Benamrane, 2012), we also used a
polynomial kernel for PSP disease classification. We clearly
obtained an improved accuracy when comparing the accuracy
rates with the use of a polynomial and a linear kernel. Note that
the polynomial kernel allows kernel parameters that enable a
change in the balance between specificity and sensitivity. In the
future, this might be helpful when using sensitive approaches for
disease detection.
In contrast to previous studies that used whole-brain
approaches (Focke et al., 2011; Salvatore et al., 2014), we also
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showed that classification can be improved when using a disease-
specific ROI-based approach for SVM feature selection. ROIs
were defined in independent and comprehensive cohorts in
a data-driven manner with meta-analyses across whole-brain
studies (Shi et al., 2013; Shao et al., 2014; Yu et al., 2015)
avoiding circular approaches. This is in line with previous work
comparing the meta-analytically inspired ROI-based approach
with the whole-brain approach for feature selection. Combining
disease-specific ROI approaches with several imaging modalities
can improve the classification accuracy that was shown for
identification of and differentiation between Alzheimer’s disease
and frontotemporal lobar degeneration (Dukart et al., 2011,
2013). Therefore, future studies might combine ROI-based
feature selection with additional imaging modalities, such as
diffusion tensor imaging sensitive to changes in white matter
or positron-emission tomography sensitive to metabolism, or
clinical features and biomarkers from serum/cerebrospinal
fluid for PSP detection that can help us to understand the
specific pattern of disease-related brain atrophy in PSP. Further
development of SVM-based classification might complement the
radiologist’s MRI-based diagnostics for PSP disease detection and
characterization.
In sum, our study investigated structural brain differences
between PSP patients and healthy controls. To pave the way
for future application in personalized medicine, we applied
SVM classification to identify PSP on an individual level. Using
VBM, we found a major decline in GMD in the brainstem,
insula, putamen, pallidum, and also frontomedian regions. SVM
classification yielded high accuracy rates in multicentric data,
a prerequisite for application in diagnostic routine. Focusing
analyses on disease-specific ROIs and using an advantageous
kernel led to higher accuracy rates. Our study supports the
application of MRI for individual diagnosis of PSP, if combined
with SVM approaches. Classification results might also be
improved by advantageous kernel and feature selection.
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